anmelden
OMX Stockholm 30
3.292,34
PKT
+34,01
PKT
+1,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Stockholm 30-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 25.10.17 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 25.10.17 | Volvo (B) Neutral | Goldman Sachs Group Inc. | |
| 24.10.17 | Ericsson (Telefon L.M.Ericsson) (B) buy | Goldman Sachs Group Inc. | |
| 24.10.17 | Ericsson (Telefon L.M.Ericsson) (B) Hold | Kepler Cheuvreux | |
| 24.10.17 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | JP Morgan Chase & Co. | |
| 23.10.17 | Volvo (B) Neutral | Goldman Sachs Group Inc. | |
| 23.10.17 | AstraZeneca Neutral | UBS AG | |
| 23.10.17 | Ericsson (Telefon L.M.Ericsson) (B) buy | Goldman Sachs Group Inc. | |
| 23.10.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 23.10.17 | Volvo (B) buy | Citigroup Corp. | |
| 20.10.17 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 20.10.17 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | JP Morgan Chase & Co. | |
| 20.10.17 | Volvo (B) buy | S&P Capital IQ | |
| 20.10.17 | Volvo (B) Neutral | UBS AG | |
| 20.10.17 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 19.10.17 | Volvo (B) buy | HSBC | |
| 18.10.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 17.10.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 17.10.17 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 17.10.17 | ABB (Asea Brown Boveri) Sell | UBS AG | |
| 17.10.17 | Volvo (B) Neutral | UBS AG | |
| 16.10.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 16.10.17 | AstraZeneca Outperform | Credit Suisse Group | |
| 12.10.17 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | UBS AG | |
| 11.10.17 | AstraZeneca buy | Deutsche Bank AG | |
| 11.10.17 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | JP Morgan Chase & Co. | |
| 11.10.17 | ABB (Asea Brown Boveri) Hold | HSBC | |
| 10.10.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 09.10.17 | Volvo (B) Underweight | Morgan Stanley | |
| 09.10.17 | AstraZeneca Neutral | UBS AG | |
| 09.10.17 | AstraZeneca Reduce | HSBC | |
| 05.10.17 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 03.10.17 | Ericsson (Telefon L.M.Ericsson) (B) Underperform | Credit Suisse Group | |
| 02.10.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 26.09.17 | ABB (Asea Brown Boveri) Sell | Citigroup Corp. | |
| 26.09.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 26.09.17 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 25.09.17 | AstraZeneca Outperform | BNP PARIBAS | |
| 25.09.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 22.09.17 | AstraZeneca Outperform | Bernstein Research |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.
